Decoding the Lipidome: Unveiling the Role of Lipids in Renal Cell Carcinoma

Posted on June 05, 2023


In recent years, the study of lipids has emerged as a promising field of research in understanding various diseases, including cancer. Among these, Renal Cell Carcinoma (RCC), a prevalent type of kidney cancer, has garnered significant attention. Researchers have turned to innovative technologies, along with other cutting-edge tools, to explore the lipidome of RCC patients. These endeavors aim to unravel the intricate relationship between lipids and the development and progression of RCC. In this blog, we delve into the fascinating world of lipids and the role they play in RCC.

Lipids: The Building Blocks of Life

Before delving into the lipidome of RCC, let's grasp the significance of lipids in our body. Lipids are a diverse group of molecules that serve as the building blocks of cellular membranes. They not only provide structural integrity but also play crucial roles in energy storage, insulation, and cellular signaling. Beyond their structural functions, lipids act as signaling molecules and participate in complex cellular processes, including proliferation, differentiation, and apoptosis.

Understanding SPLASH: Unveiling the Lipidome

In recent research conducted by Martín-Saiz et al. (2023), an innovative approach using MALDI-MSI and HPLC-MS to explore the lipidomics of clear cell renal cell carcinoma (ccRCC). This groundbreaking technique combines the power of high-performance liquid chromatography-mass spectrometry (HPLC-MS) and matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to gain deeper insights into the lipid composition and spatial distribution within ccRCC tissue samples.

Lipidomics, a rapidly evolving field of study, focuses on understanding the complex lipid profiles present in biological samples. Aberrations in lipid metabolism have been linked to several diseases, including cancer. By analyzing the lipidome, researchers can uncover potential lipid biomarkers and better comprehend the underlying molecular mechanisms driving disease progression.

Combining the complementary strengths of HPLC-MS and MALDI-MS offers a unique advantage. HPLC-MS allows for comprehensive lipid profiling by separating complex lipid mixtures into individual components and identifying them based on their mass-to-charge ratios. On the other hand, MALDI-MSI provides spatial information, enabling the visualization and mapping of lipid distributions directly within tissue sections.

In this study, the technique was utilized to investigate the lipidomic alterations in ccRCC tissue samples obtained from patients. The researchers analyzed multiple lipid classes, including glycerophospholipids, sphingolipids, and glycerolipids, among others. By employing both HPLC-MS and MALDI-MSI, they were able to identify specific lipid species and visualize their spatial distribution within the tumor microenvironment.

The results of this study shed light on the intricate lipidomic changes occurring in ccRCC. They revealed distinct lipid profiles between tumor and adjacent non-tumor tissues, highlighting the potential of lipids as diagnostic and prognostic markers for ccRCC. Moreover, the spatial information provided by MALDI-MSI allowed for the identification of lipid hotspots within the tumor, suggesting their involvement in tumor biology and potentially serving as targets for therapeutic interventions.

The integration of HPLC-MS and MALDI-MSI demonstrates the power of combining different analytical techniques to unravel the complexities of the lipidome. By providing comprehensive lipid characterization along with spatial visualization, this could offer a valuable tool for lipidomic studies in various research areas, including cancer research, biomarker discovery, and understanding disease mechanisms.

Exploring the Lipidome of RCC:

The lipidome of RCC patients has revealed intriguing patterns and alterations that shed light on the disease's biology and progression. Lipid profiling studies utilizing SPLASH, along other standards and methodologies, have identified significant changes in lipid classes, fatty acid composition, and lipid species distribution in RCC tissues and plasma samples. These alterations encompass various lipid families, including phospholipids, sphingolipids, and sterol lipids.


Phospholipids, a major class of lipids, are essential components of cellular membranes. In RCC, altered levels of specific phospholipids have been observed. For instance, researchers have reported elevated levels of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) in RCC tissues. These alterations in phospholipid composition may influence membrane fluidity, cell signaling, and other critical cellular processes involved in cancer progression.


Sphingolipids are another important lipid family implicated in RCC. Ceramides, a type of sphingolipid, have been found to be dysregulated in RCC samples. Ceramides play diverse roles in cell growth, apoptosis, and inflammation. Altered ceramide metabolism may contribute to the dysregulation of these cellular processes, promoting RCC development and progression.

Sterol Lipids:

Sterol lipids, such as cholesterol and its derivatives, play vital roles in maintaining cellular membrane integrity and regulating membrane fluidity. Studies have indicated dysregulation of cholesterol metabolism in RCC, with altered levels of cholesterol and cholesterol esters. These lipid alterations may impact cell membrane properties and signaling pathways, ultimately influencing RCC pathogenesis.

Potential Implications and Future Directions:

The emerging understanding of the lipidome in RCC opens a plethora of possibilities for clinical applications and therapeutic interventions. By identifying lipidomic signatures associated with RCC, researchers envision the development of non-invasive diagnostic tools for early detection and monitoring of the disease. Additionally, targeting specific lipid pathways or aberrant lipid metabolism could serve as a promising avenue for novel therapeutic strategies against RCC. Understanding the intricate interplay between lipids and RCC biology will pave the way for personalized treatment approaches and improved patient outcomes.


The investigation of lipids and their impact on Renal Cell Carcinoma represents a significant breakthrough in cancer research. Through innovative techniques, scientists have uncovered a wealth of information about the lipidome of RCC patients, highlighting the role of lipids in cancer development and progression. As we continue to unveil the complex interplay between lipids and RCC, we move closer to improved diagnostic tools and targeted therapies. The study of lipids in RCC provides a prime example of how interdisciplinary research can revolutionize our understanding of cancer biology and ultimately benefit patient care.

Be sure to check out Avanti's variety of SPLASH offerings, including our new MSI SPLASH, which can be used for mass spec imaging of brain tissue!


Martín-Saiz, L., Abad-García, B., Solano-Iturri, J. D., Mosteiro, L., Martín-Allende, J., Rueda, Y., Pérez-Fernández, A., Unda, M., Coterón-Ochoa, P., Goya, A., Saiz, A., Martínez, J., Ochoa, B., Fresnedo, O., Larrinaga, G., & Fernández, J. A. (2023). Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma. Analytical Chemistry, 95(4), 2285–2293.